Patents by Inventor Shunqi Yan

Shunqi Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
    Publication number: 20240116888
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Application
    Filed: November 13, 2023
    Publication date: April 11, 2024
    Inventors: Shunqi YAN, Li-Tain YEH, Robert ORR
  • Therapeutic compounds and compositions
    Patent number: 11866411
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: January 9, 2024
    Assignee: Agios Pharmaceutical, Inc.
    Inventors: Francesco G. Salituro, Jeffrey O. Saunders, Shunqi Yan
  • THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
    Publication number: 20230250078
    Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
    Type: Application
    Filed: September 9, 2022
    Publication date: August 10, 2023
    Inventors: Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins, Shunqi Yan, Tao Guo, Li Zhang
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
    Publication number: 20230227419
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Application
    Filed: March 23, 2023
    Publication date: July 20, 2023
    Inventors: Shunqi YAN, Li-Tain YEH, Robert ORR
  • METHODS FOR TREATING OR PREVENTING CHRONIC KIDNEY DISEASE
    Publication number: 20230218563
    Abstract: Described herein are methods for treating or preventing chronic kidney disease, and other diseases, comprising the administration (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethy)benzofuran-3-yl-4,5,6,7-d4)methanone, and solvates thereof.
    Type: Application
    Filed: June 9, 2021
    Publication date: July 13, 2023
    Inventors: Litain YEH, Shunqi YAN, Rongzi YAN, Zancong SHEN
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
    Publication number: 20220396558
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Application
    Filed: August 4, 2022
    Publication date: December 15, 2022
    Inventors: Shunqi YAN, Li-Tain YEH, Robert ORR
  • Therapeutically active compounds and their methods of use
    Patent number: 11505538
    Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: November 22, 2022
    Assignee: Servier Pharmaceuticals LLC
    Inventors: Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins, Shunqi Yan, Tao Guo, Li Zhang
  • THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
    Publication number: 20220348554
    Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
    Type: Application
    Filed: June 18, 2020
    Publication date: November 3, 2022
    Inventors: Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins, Shunqi Yan, Tao Guo, Li Zhang
  • COMPOUND FOR TREATING GOUT OR HYPERURICEMIA
    Publication number: 20220242841
    Abstract: Described herein is (3,5-dibromo-4-hydroxyphenyl)(6-hydroxy-2-(1-hydroxyethyl)benzofuran-3-yl-4,5,7-d3)methanone, or a pharmaceutically acceptable salt or solvate thereof, and methods for treating or preventing gout or hyperuricemia comprising the administration of the compound.
    Type: Application
    Filed: May 13, 2020
    Publication date: August 4, 2022
    Inventors: Shunqi YAN, Litain YEH, Rongzi YAN, Zancong SHEN
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
    Publication number: 20220112171
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: Shunqi YAN, Li-Tain YEH, Robert ORR
  • Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
    Patent number: 11236058
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: February 1, 2022
    Assignee: ARTHROSI THERAPEUTICS, INC.
    Inventors: Shunqi Yan, Li-Tain Yeh, Robert Orr
  • METHODS FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA
    Publication number: 20220023251
    Abstract: Described herein are methods for treating or preventing gout or hyperuricemia comprising the administration (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3-yl-4,5,6,7-d4)methanone, and solvates thereof.
    Type: Application
    Filed: December 5, 2019
    Publication date: January 27, 2022
    Inventors: Shunqi YAN, Litain YEH, Rongzi YAN
  • CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA
    Publication number: 20220024889
    Abstract: Described herein are crystalline forms of (3,5-dibromo-4-hydroxyphenyl)(2-(1-hydroxyethyl)benzofuran-3-yl-4,5,6,7-d4)methanone, and solvates thereof.
    Type: Application
    Filed: December 5, 2019
    Publication date: January 27, 2022
    Inventors: Shunqi YAN, Litain YEH, Zheng Jane LI, Ruiping WANG
  • THERAPEUTIC COMPOUNDS AND COMPOSITIONS
    Publication number: 20210198206
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Application
    Filed: March 8, 2021
    Publication date: July 1, 2021
    Inventors: Francesco G. Salituro, Jeffrey O. Saunders, Shunqi Yan
  • Therapeutic compounds and compositions
    Patent number: 10988448
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: April 27, 2021
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Francesco G. Salituro, Jeffrey O. Saunders, Shunqi Yan
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
    Publication number: 20200148659
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 14, 2020
    Inventors: Shunqi YAN, Li-Tain YEH, Robert ORR
  • THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
    Publication number: 20200079755
    Abstract: Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 12, 2020
    Inventors: Giovanni Cianchetta, Byron DeLaBarre, Janeta Popovici-Muller, Francesco G. Salituro, Jeffrey O. Saunders, Jeremy Travins, Shunqi Yan, Tao Guo, Li Zhang
  • Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
    Patent number: 10508093
    Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: December 17, 2019
    Assignee: ARTHROSI THERAPEUTICS, INC.
    Inventors: Shunqi Yan, Li-Tain Yeh, Robert Orr
  • THERAPEUTIC COMPOUNDS AND COMPOSITIONS
    Publication number: 20190345109
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Application
    Filed: January 9, 2019
    Publication date: November 14, 2019
    Inventors: Francesco G. Salituro, Jeffrey O. Saunders, Shunqi Yan
  • Therapeutic compounds and compositions
    Patent number: RE49582
    Abstract: Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: July 18, 2023
    Assignee: AGIOS PHARMACEUTICALS, INC.
    Inventors: Francesco G. Salituro, Jeffrey O. Saunders, Shunqi Yan